Polynucleotides and PDRN
Polynucleotide (PN) and polydeoxyribonucleotide (PDRN) describe DNA-based preparations discussed in tissue research and aesthetic treatments. These names appear across different materials and delivery methods. Ask for the full ingredient name, source and formulation; a generic label such as a regenerative injectable does not identify what is being administered.
What the label does not tell you
A small randomised split-face trial compared one PN injectable with non-cross-linked HA in the eye area. Some measured outcomes favoured PN, while overall aesthetic scores did not differ significantly. Its 27 participants cannot establish all uses, all formulations or long-term rare risks. A separate PDRN combination study used cells and an animal model; it does not establish that injecting PDRN improves human skin. Wound-healing findings also do not automatically prove cosmetic benefit.
Questions to bring
Is this PN, PDRN or a combination and what else does it contain? What is the source material and does my allergy history affect suitability? Is the evidence for this exact preparation, route and area? What benefits remain uncertain and what reactions need follow-up?
Evidence and scope
Aesthetic evidence is formulation-specific and still developing. Avoid claims that a PN trial proves a PDRN product or that absence of serious events in a small study proves absence of risk.
Read the original sources
Sources describe specific products, studies or countries. They do not establish approval everywhere.
General education. Your clinician can assess your individual suitability. Rules depend on the treatment country; FDA references concern the United States. External sources may be in another language.